Gary Steinberg specializes in urologic oncology. His practice includes the management of patients with bladder, kidney, testicular, and prostate cancers. Dr. Steinberg's research includes developing newer treatments for urologic cancers, especially locally advanced bladder and kidney cancer. He is involved in a large number of clinical trials for patients with non-muscle invasive and invasive bladder cancer and kidney cancer as well as studies identifying newer molecular markers for the detection of bladder cancer. He is a national leader in continent urinary tract reconstruction and is the principal investigator for a regenerative medicine project using a patient’s own stem cells to create urinary tract reconstructions without using the intestine. Dr. Steinberg is also the chairperson of the scientific advisory board of the Bladder Cancer Advocacy Network and the executive committee of the Bladder Cancer Research Network.